文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Bockarie Koroma
发表
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
D. Watson-Jones, C. McLean, G. Deen, 2022, The Lancet. Infectious diseases.